These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin. Murray JL; Dowd J; Hersh EM J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703 [TBL] [Abstract][Full Text] [Related]
23. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Griga T; Hebler U; Voigt E; Tromm A; May B Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression. Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420 [TBL] [Abstract][Full Text] [Related]
27. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Lassus A; Lauharanta J; Eskelinen A Br J Dermatol; 1985 Apr; 112(4):455-9. PubMed ID: 3888246 [TBL] [Abstract][Full Text] [Related]
28. Lymphokines and aging: interleukin-2 production and activity in aged animals. Thoman ML; Weigle WO J Immunol; 1981 Nov; 127(5):2102-6. PubMed ID: 6457862 [TBL] [Abstract][Full Text] [Related]
29. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. Sakiyama H; Kobayashi S; Dianzani U; Ogiuchi H; Kawashima M; Uchiyama T; Yagi J J Dermatol Sci; 2008 Jun; 50(3):197-207. PubMed ID: 18308514 [TBL] [Abstract][Full Text] [Related]
30. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Kitas GD; Salmon M; Farr M; Gaston JS; Bacon PA Clin Exp Immunol; 1988 Aug; 73(2):242-9. PubMed ID: 2972426 [TBL] [Abstract][Full Text] [Related]
31. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Hurtado-Nedelec M; Chollet-Martin S; Nicaise-Roland P; Grootenboer-Mignot S; Ruimy R; Meyer O; Hayem G Rheumatology (Oxford); 2008 Aug; 47(8):1160-7. PubMed ID: 18559374 [TBL] [Abstract][Full Text] [Related]
32. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract. Kovacs E Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963 [TBL] [Abstract][Full Text] [Related]
33. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337 [TBL] [Abstract][Full Text] [Related]
34. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. Fox RI; Theofilopoulos AN; Altman A J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375 [TBL] [Abstract][Full Text] [Related]
35. Palmoplantar pustulosis and pustulotic arthro-osteitis associated with multiple venous occlusion: A case report and literature review. Inoue E; Hiroumi S; Sato S; Hayashi M; Konaka H; Tsuji S; Higashiyama M J Dermatol; 2023 Aug; 50(8):1076-1080. PubMed ID: 37017424 [TBL] [Abstract][Full Text] [Related]
36. Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. I. Characterization of the inhibitor and its mechanism of action. Smith MD; Haynes DR; Roberts-Thomson PJ J Rheumatol; 1989 Feb; 16(2):149-57. PubMed ID: 2787402 [TBL] [Abstract][Full Text] [Related]
37. Regulation of interleukin-2 production in rheumatoid arthritis. Combe B; Andary M; Klein B; Clot J; Sany J J Rheumatol; 1987 Apr; 14(2):226-9. PubMed ID: 3496450 [TBL] [Abstract][Full Text] [Related]
38. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients. Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL Thymus; 1997; 24(3):147-56. PubMed ID: 9151380 [TBL] [Abstract][Full Text] [Related]
39. Skeletal disease, arthro-osteitis, in adult patients with pustulosis palmoplantaris. Jurik AG; Helmig O; Graudal H Scand J Rheumatol Suppl; 1988; 70():3-15. PubMed ID: 2453079 [TBL] [Abstract][Full Text] [Related]
40. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Deviere J; Content J; Denys C; Vandenbussche P; Schandene L; Wybran J; Dupont E Clin Exp Immunol; 1989 Aug; 77(2):221-5. PubMed ID: 2505958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]